System Transmission

Top Signal

100#1 JOB

Activity

2184Ripe

+961 today

System

Live1m

Terminal Asset View

stockNASDAQ

CING

$8.69-4.71%

Cingulate Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

19Overripe

Live Analysis Active

Company Mission

Cingulate Inc creates extended-release medications for ADHD, which help patients manage symptoms longer. Doctors prescribe these drugs to children and adults who need consistent treatment. The company makes money by selling these medications and forming partnerships with other firms.

CIN

Industry Context

This company operates in the pharmaceutical sector, focusing on treatments for attention deficit hyperactivity disorder (ADHD). It aims to develop medications with extended-release technology to provide better symptom control. The industry is competitive, with many firms seeking to improve existing therapies. Success depends on clinical trial results and regulatory approvals.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

36Matrix

Market Momentum

68.9— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.4x— Normal Volume

Today's Change

-4.71%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing CING across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 02:43 AM UTC

As-of As of 2026-03-16T02:28:35.331Z UTC (~15m delay).

Develops ADHD medications with a unique timed-release technology, aiming to improve patient outcomes and generate revenue through drug sales.

Weekly chart shows range contraction near $0, indicating a coiling pattern that often precedes breakouts. Watch for price breaking above this level.

No technical indicators available, but monitor if price holds above $0, signaling potential stability in a volatile market. Watch for any new data.

Industry trend toward improved ADHD treatments is driving interest, with price near $0, signaling growth potential. Watch for sector developments.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...